viewFutura Medical PLC

Futura Medical announce regulatory and commercial progress on erectile disfunction gel

Futura Medical PLC's (LON:FUM) James Barder talks to Proactive London's Katie Pilbeam about the announcement made today on the regulatory progress in the US.

Barder also hints upon significant commercial interest for its erectile dysfunction gel with talks ongoing with a growing number of potential partners.

Med3000 is an over-the-counter treatment and as a consequence would have huge commercial potential. Barder is confident the negotiations with the FDA will be satisfactorily and is planning for a Q1 confirmation.

Quick facts: Futura Medical PLC

Price: 15.75 GBX

Market: AIM
Market Cap: £38.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...



Market report: FTSE falls as hopes of US stimulus package before election wanes

FTSE 100 opened lower amid continued scepticism about a US stimulus package before next month’s election. London’s index of big caps dived 40 points to 5,735 in early trading.   Chancellor Rishi Sunak is expected to announce more support for workers in areas placed under tier 2 of local...

on 22/10/20

2 min read